Bayer Stock Forecast for 2022 - 2025 - 2030

Updated on 05/19/2022

Stock Rating
5 / 10
Price Target
67.79€
Consensus
Outperform
Upside
19.12%
Analysts
14
Stock Rating
5
Upside
19.12%
Analysts
14
Price Target
67.79€

According to fourteen esteemed experts, the average price target for Bayer to reach this year is 76.00€, with a potential upside of approximately 19.12%. This prediction is based on a high estimate of 122.62€ and a low estimate of 55.00€. If you want to invest in BAYN stock, you might also want to take a look at how its competitors are doing.

76.00€

19.12% Upside

Outperform
Outperform

Bayer Price Forecast for 2022 - 2025 - 2030

In the last three years, Bayer's Price has grown by 9.6%, rising from 57.62€ to 63.15€. For next year, analysts predict earnings per share of 65.08€, which would mean an increase of 3.06%. Over the next nine years, experts predict that Bayer's Price will grow at a rate of 20.88%.

2022 Price Forecast
65.08€
2023 Price Forecast
66.16€
2024 Price Forecast
67.58€
2025 Price Forecast
69.09€
2026 Price Forecast
70.45€
2027 Price Forecast
71.91€
2028 Price Forecast
73.38€
2029 Price Forecast
74.84€
2030 Price Forecast
76.33€
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
ABBV Stock Forecast AbbVie Outperform 5
$152.43 $152.52 10.21% 19
ABT Stock Forecast Abbott Laboratories Outperform 7
$112.74 $141.24 24.18% 19
AZN Stock Forecast AstraZeneca PLC Outperform 3
£102.44 £136.08 42.07% 13
COST Stock Forecast Costco Wholesale Outperform 6
$429.40 $595.76 38.57% 12
DHR Stock Forecast Danaher Outperform 5
$243.60 $339.17 37.52% 7

Bayer Revenue Forecast for 2022 - 2025 - 2030

In the last three years, Bayer's Revenue has grown by 19.97%, rising from 36742.00€ to 44081.00€. For next year, analysts predict earnings per share of 48030.66€, which would mean an increase of 8.96%. Over the next nine years, experts predict that Bayer's Revenue will grow at a rate of 77.63%.

2022 Revenue Forecast
48.03€k
2023 Revenue Forecast
51.15€k
2024 Revenue Forecast
54.63€k
2025 Revenue Forecast
58.40€k
2026 Revenue Forecast
62.08€k
2027 Revenue Forecast
65.96€k
2028 Revenue Forecast
69.97€k
2029 Revenue Forecast
74.07€k
2030 Revenue Forecast
78.30€k
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
BMY Stock Forecast Bristol-Myers Squibb Outperform 8
$77.02 $76.69 1.27% 16
AMGN Stock Forecast Amgen Hold 8
$243.96 $246.46 1.45% 13
DE Stock Forecast Deere & Outperform 5
$368.67 $409.08 20.84% 17

Bayer Dividend per Share Forecast for 2022 - 2025 - 2030

In the past three years, Bayer's DPS has decreased by 28.57%, going from 2.80€ to only 2.00€. For next year, analysts predict earnings per share of 2.27€, which would mean an increase of 13.33%. Over the next nine years, experts predict that Bayer's DPS will grow at a rate of 154.8%.

2022 Dividend Forecast
2.27€
2023 Dividend Forecast
2.66€
2024 Dividend Forecast
2.89€
2025 Dividend Forecast
3.23€
2026 Dividend Forecast
3.58€
2027 Dividend Forecast
3.92€
2028 Dividend Forecast
4.30€
2029 Dividend Forecast
4.69€
2030 Dividend Forecast
5.10€
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
GSK Stock Forecast GlaxoSmithKline Outperform 1
£17.70 £16.08 1.69% 11
CSL Stock Forecast CSL Outperform 4
$266.28 $228.01 -14.01% 10
GILD Stock Forecast Gilead Sciences Outperform 5
$63.22 $75.96 9.14% 19

Bayer Free Cash Flow Forecast for 2022 - 2025 - 2030

Bayer's Free Cash Flow have decreased by 53.46% in the past three years, from 5324.00€ to just 2478.00€. In the next year, analysts believe that Free Cash Flow will reach a reasonable 3536.02€ – an increase of 42.7%. For the next nine years, experts predict that Bayer's Free Cash Flow will grow at a rate of 698.99%.

2022 Free Cash Flow Forecast
3.54€k
2023 Free Cash Flow Forecast
5.35€k
2024 Free Cash Flow Forecast
6.49€k
2025 Free Cash Flow Forecast
8.25€k
2026 Free Cash Flow Forecast
10.26€k
2027 Free Cash Flow Forecast
12.26€k
2028 Free Cash Flow Forecast
14.59€k
2029 Free Cash Flow Forecast
17.11€k
2030 Free Cash Flow Forecast
19.80€k
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
BDX Stock Forecast Becton, Dickinson and Outperform 5
$251.10 $270.20 13.5% 3
CL Stock Forecast Colgate-Palmolive Hold 4
$75.71 $84.90 8.31% 9
DOW Stock Forecast Dow Outperform 3
$68.91 $64.10 7.39% 11

Bayer Net Income Forecast for 2022 - 2025 - 2030

In the past three years, BAYN's Net Income has decreased from 1695.00€ to 1000.00€ – a 41% drop. For the following year, the 0 analysts predict that BAYN's Net Income will drop by 317.32%, reaching -16528.31€. In 2030, the professionals' prediction is that BAYN's Net Income will decrease by 1752.83%, reaching -16528.31€.

2022 Net Income Forecast
-2173.17€
2023 Net Income Forecast
4.09€k
2024 Net Income Forecast
-11676.23€
2025 Net Income Forecast
-16654.20€
2026 Net Income Forecast
-13988.97€
2027 Net Income Forecast
-19779.47€
2028 Net Income Forecast
-17134.30€
2029 Net Income Forecast
-17431.86€
2030 Net Income Forecast
-16528.31€
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
BAS Stock Forecast BASF Outperform 5
49.86€ 78.27€ 28.36% 16
CTVA Stock Forecast Corteva Outperform 1
$57.09 $53.33 12.1% 13
BAX Stock Forecast Baxter International Outperform 5
$72.12 $92.47 24.79% 3

Bayer EBITDA Forecast for 2022 - 2025 - 2030

Bayer's EBITDA has seen impressive growth in the last three years, rising from 7145.00€ to 8423.00€ – a growth of 17.89%. In the next year, analysts believe that EBITDA will reach a reasonable 10132.03€ – an increase of 20.29%. For the next nine years, the forecast is for EBITDA to grow by 225.13%.

2022 EBITDA Forecast
10.13€k
2023 EBITDA Forecast
11.61€k
2024 EBITDA Forecast
13.54€k
2025 EBITDA Forecast
15.52€k
2026 EBITDA Forecast
17.58€k
2027 EBITDA Forecast
19.85€k
2028 EBITDA Forecast
22.22€k
2029 EBITDA Forecast
24.73€k
2030 EBITDA Forecast
27.39€k
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
GIVN Stock Forecast Givaudan Hold 3
CHF4.04k CHF4.11k -0.97% 15
DD Stock Forecast DuPont de Nemours Outperform 3
$64.28 $98.25 36.9% 7
SGO Stock Forecast Compagnie de Saint-Gobain Outperform 5
53.69€ 71.19€ 35.97% 9

Bayer EBIT Forecast for 2022 - 2025 - 2030

In the past three years, Bayer's EBIT has grown by 68.01%, rising from 4257.00€ to 7152.00€. For the next year, analysts predict that EBIT will reach 8139.69€ – an increase of 13.81%. Over the next nine years, experts believe that BAYN's EBIT will grow at a rate of 80%.

2022 EBIT Forecast
8.14€k
2023 EBIT Forecast
8.53€k
2024 EBIT Forecast
9.04€k
2025 EBIT Forecast
9.72€k
2026 EBIT Forecast
10.28€k
2027 EBIT Forecast
10.90€k
2028 EBIT Forecast
11.55€k
2029 EBIT Forecast
12.20€k
2030 EBIT Forecast
12.87€k
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
BIIB Stock Forecast Biogen Outperform 4
$195.71 $287.21 16.24% 24
4503 Stock Forecast Astellas Pharma Outperform 2
¥1.80k ¥0.00 33.33% 0
BEI Stock Forecast Beiersdorf Outperform 4
95.16€ 102.71€ 11.39% 13

Bayer EPS Price Prediction Forecast for 2022 - 2025 - 2030

In the last three years, Bayer's EPS has grown by 9.6%, rising from 5.94€ to 6.51€. For next year, analysts predict earnings per share of 6.71€, which would mean an increase of 3.06%. Over the next nine years, experts predict that Bayer's EPS will grow at a rate of 20.88%.

2022 EPS Forecast
6.71€
2023 EPS Forecast
6.82€
2024 EPS Forecast
6.97€
2025 EPS Forecast
7.12€
2026 EPS Forecast
7.26€
2027 EPS Forecast
7.41€
2028 EPS Forecast
7.56€
2029 EPS Forecast
7.72€
2030 EPS Forecast
7.87€
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
CHD Stock Forecast Church & Dwight Hold 5
$90.19 $88.52 10.88% 9
1301 Stock Forecast Formosa Plastics Outperform 6
NT$104.50 NT$125.45 24.88% 0
GMAB Stock Forecast Genmab A/S Outperform 5
kr2.22k kr2.84k 24% 13

© Copyright 2022 | Stock Forecast | All Rights Reserved